Condition 1: Scores Pain after injection of sulfate magnesium. Condition 2: duration of analgesia after injection of sulfate magnesium. Acute pain Acute pain
Conditions
Interventions
Intervention 1: Intervention group: In the first intervention group, the patient received 2 cc Bupivacaine 0.5%+ 0.3 cc normal saline+0.5 cc magnesium sulfate 10% (group M50) at the beginning of surg
the score of pain, duration of analgesia and Hemodynamic signs measured and recorded at mentioned time. Intervention 2: Control group: patients received 2 cc Bupivacaine 0.5%+ 0.8 cc normal saline at
the score of pain, duration of analgesia and Hemodynamic signs measured and recorded at mentioned time.
Treatment - Drugs
Placebo
Intervention group: In the first intervention group, the patient received 2 cc Bupivacaine 0.5%+ 0.3 cc normal saline+0.5 cc magnesium sulfate 10% (group M50) at the beginning of surgery and after en
the score of pain, duration of analgesia and Hemodynamic signs measured and recorded at mentioned time.
Control group: patients received 2 cc Bupivacaine 0.5%+ 0.8 cc normal saline at the same time with the start of surgery and their score of pain, duration of analgesia and Hemodynamic signs recorded af
Intervention group: In the second intervention group, the patient received 2 cc Bupivacaine 0.5%+ 0.8 cc magnesium sulfate 10% (group M80) at the beginning of surgery and after entering the maternity
Sponsors
Vice chancellor for research, Jahrom University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: All the patients who are going to do cesarean section at Motahari hospital affiliated to Jahrom University of Medical Sciences, can receive spinal anesthesia, Informed consent for participation in this study. Exclusion criteria: education under primary school, chronic pains and cancer, lack of mental and psychological health, chronic use of painkillers and narcotics, Unstable hemodynamic status, expressing disagreement for continuing the research.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of analgesia. Timepoint: The first time of pain by mother. Method of measurement: According to time. | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital Signs. Timepoint: Every 4 hours after surgery Within 48 hours(2 days). Method of measurement: Monitoring Blood pressure, Heart Rate, Breathing. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzaneh Mehran
Jahrom University of Medical Sciences
Outcome results
None listed